Oropharyngeal candidiasis is the most common opportunistic fungal infection in individuals infected with human immunodeficiency virus. CD4
INTRODUCTION
Candida species that colonize the oral cavity are the source of the yeasts that cause oral candidiasis (OC) 5 . Oropharyngeal candidiasis (OPC) is the most common opportunistic fungal infection in individuals infected with human immunodeficiency virus 2, 8, 12 .
A vast majority of HIV-positive patients develop clinical lesions of oropharyngeal or esophageal candidosis that can increase in frequency and severity with HIV disease progression 14 . Marked decrease in incidence of oral lesion has been reported in patients receiving highly active antiretroviral therapy (HAART) related to the improvement in immunological function or to inhibition of the fungal secretory aspartyl proteinases (SAPs) that play a pathogenic role in mucosal invasion 1 . Other mechanisms seem to play a fundamental role for the declining rates of OPC 9, 22 . It has been suggested that low CD4 + lymphocytes count and high plasma HIV RNA levels significantly correlate with oral Candida carriage, thereby increasing the risk of developing symptomatic infections 21 . There are controversies about association of CD4 + cell count and viral load with asymptomatic oral yeast carriage. FONG et al. 11 found a correlation between asymptomatic yeast carriage, development of thrush, and low CD4 + cell count in HIV+ patients. CAMPISI et al. 3 verified that in AIDS patients there was more oral Candida colonization than control-subjects, but this characteristic was not associated with CD4 + cell count or viral load.
So, in an attempt to answer this question, we conducted the present study to evaluate Candida spp. diversity in the oral cavity of HIVinfected patients and to determine whether the oral Candida colonization in these patients was associated with CD4 + cell count or plasma HIV-1 RNA levels.
MATERIALS AND METHODS
Patients, sampling and culture of clinical isolates: This prospective study was conduced from May 2004 to May 2005, in which oral mucosa samples were collected from 99 HIV-infected patients (confirmed by Elisa and Western blot). The Hospital de Doenças Tropicais (HDT) in Goiás, Brazil, was requested to send samples of these patients. All the participants provided informed consent before enrollment and the Bioethics Committee of HDT approved the study.
The patients who had received treatment with antibiotics or antifungal within the last three months for therapeutic or prophylactic purposes were excluded from this study. It was established a protocol that contained data as sex, age and if they were undergoing to highly active antiretroviral therapy that included HIV protease inhibitors (Indinavir, Saquinavir) and nucleoside reverse transcriptase inhibitors (Zidovudine and Lamivudine). These patients had no clinical signals of oral lesions HIV-related at clinical examination and the time of HIV diagnosis ranged from six months to 15 years (mean = seven years).
In all patients included in this study, microbiological samples were obtained by swabbing the palatine mucosa and dorsal tongue with sterile cotton swabs. These materials were then cultured aerobically on Sabouraud glucose agar at room temperature for seven days. The cultures were inspected on a daily basis for yeast growth and the pure cultures were stored in glycerine at -70 o C until the use of them.
Identification of isolates:
All isolates were identified by germ tube test, chlamydoconidia production on cornmeal agar supplemented with 1% tween 80 and by sugar and nitrogen assimilation tests 17 . Identification was confirmed by API 20C AUX identification System for yeasts (BioMerieux, Marcy L'Etoile, France). C. albicans ATCC 10231 and C. parapsilosis 22019 were included as control. Additional tests as cultivation on CHROMagar Candida medium (CHROMagar, Paris, France), growth at 45 o C on agar Sabouraud dextrose and in hypertonic Sabouraud broth, and assimilation tests by using xylose and α-metil-D-glucoside 7,10 were used to help us to discriminate between C. albicans and Candida dubliniensis.
CD4
+ lymphocytes and viral load measurements: Plasma HIV-1 RNA levels and CD4 + cell counts were measured within 48 hours of collect of oral mucosa samples. CD4 + cell counts were obtained from peripheral blood samples collected in ethylenediamine tetraacetic acid as anticoagulant, prepared by a whole blood lysis technique and analyzed on a FACScan flow cytometer (Becton Dickinson, San Jose, California, USA), using a two-colour monoclonal antibody panel 1 .
Plasma viral load was measured using the Versant HIV-1 RNA 3.0 branched DNA assay (Bayer PLC, Newbury, UK) with a lower limit of detection of 50 HIV-1 RNA copies/mL 15 .
Data analysis:
The statistical analysis was performed using Statistical Programme for Social Sciences (SPSS) 11.0 for Windows. A Fisher exact test was used to determine differences in proportion of categorized variables. Continuous variables with an approximately normal distribution were tested with the Student's test. The MannWhitney test was used to determine significant associations of carrier rates with CD4 + cell count and HIV-1 viral load. A p value of < 0.05 was considered statistically significant.
RESULTS
Out of 99 patients investigated, 62 (62.6%) were found to be colonized with yeasts (oral carriage) and 37 patients (37.4%) had Candida negative culture (no oral carriage). Among the 62 isolates, C. albicans was the most frequently isolated species (50%), followed by C. tropicalis (20.9%). Candida non-albicans species were recovered in 31 isolates (50%) ( Table 1 ).
The mean age of oral Candida carriage patients was 37.1 years (53.2% were male), while for no oral carriage the mean age was 37.9 years (56.7% were male). There was no significant difference between oral carriage and no oral carriage patients of Candida sp. with the respect to gender, age or antiretroviral therapy. Demographic data, and the use of antiretroviral therapy of the 99 patients are summarized in Table 2 .
A broad range of CD4 + and viral load was observed. The range of CD4 + was 6-2305 cells/mm 3 in colonized patients and 3-839 cells/ mm 3 for non-colonized patients, while the viral load was 60-90016 copies/mL for colonized patients and 75-110488 copies/mL for non colonized patients. The viral load was undetectable in 15 colonized patients and in 12 non colonized patients (lower limit of detection of 50 HIV RNA copies/mL). ) and by viral load measurement (51-500, between 501-20000 and > 20000 copies/mL) ( Table 3) .
DISCUSSION
Asymptomatical carriage of Candida species is a common finding in HIV positive patients. In our study we demonstrated a high rate of oropharyngeal carriage of Candida (62.6%) in HIV-infected subjects. This prevalence is similar with that reported by GUGNANI et al.
14 , who found an oral yeast carriage rate of 65.3% in HIV-seropositive patients, by CAMPISI et al. 3 who discovered a proportion of 61.9% in these patients and by SANCHEZ-VARGAS et al. 23 that observed in 66.7% of HIV/AIDS patients colonization or infection by yeasts. There are few studies about oral carriage of Candida species and oral infection, but FONG et al. 11 have demonstrated that persistent asymptomatic carriage of Candida species is a possible risk factor for subsequent oral infection.
Among Candida spp. recovered from HIV-infected patients in our study, C. albicans was the most common species (50%) but Candida non albicans species responded for 50% of all cases. C. tropicalis was the second species most frequently isolated (20.9%). The emergence of C. tropicalis in HIV-infected individuals has been reported by other authors 24, 25 . This organism appears to be prevalent in tropical climates 25 .
Although C. dubliniensis described by SULLIVAN et al. 27 has been recovered principally associated with oral cavities of HIV-infected individuals, this species was not isolated in our study. The prevalence of C. dubliniensis isolates in determined populations remains uncommon in HIV-infected patients 19, 23, 25 . The absence of this species above related, of C. glabrata and only one C. krusei isolate in our group may be explained by the subjects' exposure lack to antifungal agents during the previous three months. The incidence of these species has been attributed to the widespread use of fluconazole as prophylactic therapy 4 .
Highly active antiretroviral therapy has been associated with a dramatic decrease in the rates of HIV related opportunistic infections 16 . Antiretroviral therapy including inhibitors protease (PIs) can exert a direct effect on Candida virulence by inhibiting the fungal secretory aspartyl proteinases (SAPs) 21 . In this study we did not find significant correlation between the status of Candida carrier and the antiretroviral therapy. This could be explained by characteristics of isolates studied. All the isolates were considered commensal yeasts and not infecting strains, so probably producing low levels of SAPs and thereby reducing the potential target for the antiretroviral agents. This finding supports the premise that strains of C. albicans isolated from patients with candidiasis have higher SAPs levels than strains isolated from asymptomatic carriers 6 .
Although a substantial set of epidemiological data exists regarding the prevalence of Candida species in HIV positive individuals and its increase with disease progression, few studies have been performed about asymptomatic oral yeast carriage and its relationship to markers of immunodeficiency and HIV viral replication.
In the present study we did not find a significant correlation between oral carriage and CD4 + cell count or HIV-1 RNA in plasma (mean values and stratified trends). These results were similar to the studies of CAMPISI et al. 3 , but contrast with those of SCHOOFS et al. 26 that reported a significant relationship between carriage rate and CD4+ cell counts less than 200 cells/mm 3 . Our data only partially agree with those of GOTTFREDSSON et al. 13 that found a positive association between HIV-1 RNA levels and yeast colonization in HIV patients but no correlation with CD4 + cell counts.
Despite the fact that 14.5% (9/62) of the oral carriage had their CD4 + cell count low of 200 cells/mm 3 and 27.4% (17/62) had their viral load above 20000 copies/mL no patient had oral lesions by Candida. Oropharyngeal candidiasis has been demonstrated to be associated with oral yeast colonization and decline in CD4 + cell count 22 . The precise defense mechanisms that limit Candida proliferation are still undefined. Other factors such as blood group secretor status, salivary low rates, antimicrobial constituents of saliva, lysozyme and lactoferrin release, presence of normal bacteria flora and local mucosal immune system could have an impact on the development of oral infection by Candida 18, 28 .
In conclusion, oral colonization of Candida spp. especially C. albicans was detected with high frequency in HIV-infected patients. Early detection of oral carriage of Candida spp. is seen to be important for identification of patients with the propensity for rapid progression of HIV infection since oral carriage may influence the development of clinically significant candidiasis in these immunocompromised patients. We have also shown that the status of oral Candida carrier is not associated with the number of CD4 cells or the viral load.
RESUMO

Carreadores assintomáticos de espécies de Candida na mucosa bucal de pacientes infectados pelo HIV na era da terapia antiretroviral
Candidíase de orofaringe é a infecção fúngica oportunística mais comum em indivíduos infectados com o vírus da imunodeficiência humana. Contagem de linfócitos CD4 + e quantificação de RNA viral no plasma sanguíneo são os principais marcadores da progressão da doença pelo HIV. O presente estudo foi conduzido para avaliar a diversidade de espécies de Candida presentes na cavidade bucal de pacientes infectados pelo HIV e para determinar se havia associação de contagem de células CD4 + e de carga viral com carreadores assintomáticos de Candida, na mucosa bucal. Dos 99 pacientes HIV positivo estudados, 62 (62,6%) apresentaram cultura positiva para Candida sp. sendo denominados carreadores de Candida e os 37 pacientes (37,4%) que não possuíam leveduras do gênero Candida na mucosa bucal foram denominados não carreadores. Os agentes etiológicos mais comuns foram C. albicans e C. tropicalis. A variação de CD4 + foi de 6-2305 cels/mm 3 em pacientes colonizados e de 3-839 cels/mm 3 para pacientes não colonizados, enquanto a carga viral variou de 60-90016 cópias/mL para pacientes colonizados e de 75-110488 cópias/mL para não colonizados. Não foi possível a detecção de carga viral em 15 pacientes colonizados e em 12 não colonizados, porque o limite mínimo de detecção era de 50 cópias/mL. Nossos resultados mostraram que não houve diferença significante na contagem de células CD4 + e de carga viral entre os pacientes carreadores e não carreadores de Candida na mucosa bucal de pacientes com AIDS.
